Revisiting argenx: Leader In FcRn Space Offers Upside Potential In 2020 And Beyond [Seeking Alpha]
MOMENTA PHARMACEUTICALS (MNTA)
Last momenta pharmaceuticals earnings: 2/26 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.momentapharma.com/investor-relations
Company Research
Source: Seeking Alpha
Revisiting argenx: Leader In FcRn Space Offers Upside Potential In 2020 And Beyond Summary Shares have risen by 385% since my initial recommendation and by 120% since my last update. I provide a recap of our bullish thesis and progress in the company's promising pipeline. Key catalysts await in 2020, including pivotal results in lead indication Generalized Myasthenia Gravis. Risks include setbacks in the clinic and increased competition in the FcRn space, with other players, including UCB with rozanolixizumab, Momenta Pharmaceuticals and Health Sciences Acquisitions Corporation/Immunovant. argenx is a Buy. This one appears to be more of a long term, core-type story at this point. Shares of argenx (NASDAQ: ARGX my August 2017 article December 2017 update While we did log a triple in ROTY's model account, the initial lesson here for me is that I sold too early, and further patience would have paid off (when thesis for a holding of yours continues to strengthen significantly, often it's
Show less
Read more
Impact Snapshot
Event Time:
MNTA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MNTA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MNTA alerts
High impacting MOMENTA PHARMACEUTICALS news events
Weekly update
A roundup of the hottest topics